Financhill
Sell
27

CRSP Quote, Financials, Valuation and Earnings

Last price:
$37.78
Seasonality move :
21.79%
Day range:
$37.23 - $38.22
52-week range:
$30.04 - $67.88
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.68x
Volume:
1M
Avg. volume:
2.2M
1-year change:
-32.02%
Market cap:
$3.2B
Revenue:
$35M
EPS (TTM):
-$4.37

Earnings Data

Next earnings date for CRSP
May 08
2025
Most recent earnings per share
-$0.44
Beat by $0.75
(Feb 11/2025)
Consensus Estimate
-$1.19
(Feb 11/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CRSP Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/30/2025 Q2 $8.6M -- -- -$1.26 --
05/08/2025 Q1 $6M -- -- -$1.26 --
02/11/2025 Q4 $7.3M $35M -$0.44 -$1.19 $0.75
11/05/2024 Q3 $7.1M -- -$1.01 -$1.40 $0.39
08/05/2024 Q2 $13.6M -- -$1.49 -$1.42 -$0.07
05/08/2024 Q1 $26.5M -- -$1.43 -$1.46 $0.03
02/21/2024 Q4 $123.1M $200M $1.13 $0.05 $1.08
11/06/2023 Q3 -- -- -$1.41 -$1.95 $0.54
08/07/2023 Q2 -- -- -$0.98 -$2.10 $1.12
05/08/2023 Q1 -- -- -$0.67 -$1.64 $0.97
02/21/2023 Q4 -- -- -$1.41 -$2.27 $0.86
11/01/2022 Q3 -- -- -$2.24 -$2.24 -$0.00
08/08/2022 Q2 -- -- -$2.40 -$2.21 -$0.19
05/09/2022 Q1 -- -- -$2.32 -$1.97 -$0.35
02/16/2022 Q4 -- -- -$1.84 -$1.78 -$0.06
11/03/2021 Q3 -- -- -$1.67 -$1.76 $0.09
07/29/2021 Q2 -- -- $9.44 $3.12 $6.32
04/27/2021 Q1 -- -- -$1.51 -$1.47 -$0.04
02/16/2021 Q4 -- -- -$1.52 -$1.28 -$0.24
10/28/2020 Q3 -- -- -$1.32 -$1.19 -$0.13
07/27/2020 Q2 -- -- -$1.30 -$0.99 -$0.31
04/28/2020 Q1 -- -- -$1.15 -$1.04 -$0.11
02/12/2020 Q4 -- -- $0.51 $0.05 $0.46
10/28/2019 Q3 -- -- $2.40 $1.79 $0.61
07/29/2019 Q2 -- -- -$1.01 -$0.90 -$0.11
04/29/2019 Q1 -- -- -$0.93 -$0.90 -$0.03
02/25/2019 Q4 -- -- -$0.92 -- --
11/07/2018 Q3 -- -- -$1.07 -- --
08/07/2018 Q2 -- -- -$0.82 -- --
05/08/2018 Q1 -- -- -$0.62 -- --
03/08/2018 Q4 -- -- $0.01 -- --
11/08/2017 Q3 -- -- -$0.62 -- --
08/10/2017 Q2 -- -- -$0.56 -- --
03/31/2017 Q1 -- -- -$0.54 -- --
12/31/2016 Q4 -- -- $0.43 -- --
09/30/2016 Q3 -- -- -$0.37 -- --
06/30/2016 Q2 -- -- -$0.43 -- --
03/31/2016 Q1 -- -- -$0.29 -- --
12/31/2015 Q4 -- -- -$0.42 -- --
09/30/2015 Q3 -- -- -$0.22 -- --

CRISPR Therapeutics AG Earnings Questions

  • How Much did CRISPR Therapeutics AG Generate in Revenue Last Quarter?

    CRISPR Therapeutics AG reported $35M worth of top line sales in its most recent quarter.

  • Did CRISPR Therapeutics AG Beat Earnings Last Quarter?

    CRISPR Therapeutics AG announced earnings per share of -$0.44 which represents a beat of analyst forecast a -$1.19 per share.

  • Is CRISPR Therapeutics AG Profitable?

    CRISPR Therapeutics AG reported $35M that represents $0.41 per share over the last quarter.

  • What is the Analyst Consensus for CRISPR Therapeutics AG EPS Next Year?

    CRISPR Therapeutics AG's earnings are forecast to decrease from -$4.34 per share to -$5.12 per share next year representing a decrease of -12.39%.

  • When is CRISPR Therapeutics AG's Earnings Date?

    CRISPR Therapeutics AG's next earnings date is May 8, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Uber Stock a Buy, Sell or Hold?
Is Uber Stock a Buy, Sell or Hold?

Uber (NYSE:UBER) has been through quite a ride over the…

Is Micron a Good Stock to Buy Now?
Is Micron a Good Stock to Buy Now?

Like most of its peers in the semiconductor industry, Micron…

Is Uber Finally on the Path to Consistent Profitability?
Is Uber Finally on the Path to Consistent Profitability?

After posting massive losses quarter after quarter for years, Uber…

Stock Ideas

Sell
50
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 32x

Sell
47
Is MSFT Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 31x

Sell
46
Is NVDA Stock a Buy?

Market Cap: $2.5T
P/E Ratio: 35x

Alerts

Sell
23
UNH alert for Apr 18

UnitedHealth Group [UNH] is down 22.4% over the past day.

Sell
32
MAN alert for Apr 18

ManpowerGroup [MAN] is down 19.07% over the past day.

Sell
24
GPN alert for Apr 18

Global Payments [GPN] is down 17.44% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock